Lundbeck, Xellia, others targeted in UK antitrust suit by health bodies
Drugmakers including Lundbeck, Arrow Generics, Merck KGaA and Xellia are the target of an antitrust lawsuit by health authorities in the UK. The companies targeted are the same as those handed...To view the full article, register now.
Already a subscriber? Click here to view full article